Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 24, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.67B | $398.70 | $491.28 | 23.22% | 23.93% | Strong Buy | Strong Buy | 25 | 19 | 29.80% | 247.23% | 1,231.98% | 59.39% |
| ONC | BEONE MEDICINES LTD | $34.60B | $312.32 | $390.88 | 25.15% | 25.19% | Strong Buy | Strong Buy | 8 | 6 | 120.82% | 371.20% | 3,252.07% | 1,759.41% |
| FIX | COMFORT SYSTEMS USA INC | $34.05B | $965.37 | $1.17k | 20.68% | 21.97% | Strong Buy | Strong Buy | 3 | 2 | 9.56% | 13.34% | 54.59% | 21.10% |
| NVT | NVENT ELECTRIC PLC | $16.78B | $103.97 | $125.00 | 20.23% | 19.81% | Strong Buy | Strong Buy | 8 | 7 | 11.19% | 8.79% | 20.97% | 11.25% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $14.68B | $147.28 | $180.50 | 22.56% | 22.95% | Strong Buy | Strong Buy | 16 | 13 | 12.37% | 26.67% | 45.93% | 32.34% |
| VTRS | VIATRIS INC | $13.84B | $12.02 | $15.00 | 24.79% | 24.79% | Strong Buy | Strong Buy | 2 | 2 | 1.67% | N/A | 22.54% | 9.05% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.30B | $169.47 | $204.46 | 20.64% | 20.64% | Strong Buy | Strong Buy | 11 | 11 | 5.83% | N/A | 40.98% | 14.29% |
| SGHC | SUPER GROUP (SGHC) LTD | $6.05B | $11.97 | $17.83 | 48.98% | 52.46% | Strong Buy | Strong Buy | 6 | 4 | 3.65% | 25.12% | N/A | N/A |
| GTES | GATES INDUSTRIAL CORP PLC | $5.73B | $22.19 | $28.00 | 26.18% | 21.68% | Strong Buy | Strong Buy | 7 | 5 | 3.40% | 27.30% | 15.24% | 7.19% |
| CPA | COPA HOLDINGS SA | $5.02B | $121.95 | $157.80 | 29.40% | 28.19% | Strong Buy | Strong Buy | 5 | 3 | 8.06% | 12.22% | 34.95% | 14.44% |
| UGP | ULTRAPAR HOLDINGS INC | $4.03B | $3.72 | $4.50 | 20.97% | 20.97% | Strong Buy | Strong Buy | 1 | 1 | 87.00% | 89.10% | N/A | N/A |
| CALX | CALIX INC | $3.67B | $55.43 | $77.75 | 40.27% | 40.27% | Strong Buy | Strong Buy | 4 | 4 | 11.42% | N/A | 20.96% | 17.66% |
| SPNT | SIRIUSPOINT LTD | $2.62B | $22.47 | $27.50 | 22.39% | 33.51% | Strong Buy | Strong Buy | 2 | 1 | 0.31% | 24.85% | 14.93% | 2.65% |
| HCI | HCI GROUP INC | $2.54B | $195.95 | $245.00 | 25.03% | 19.93% | Strong Buy | Strong Buy | 2 | 1 | 9.93% | 2.32% | 28.12% | 9.85% |
| EXTR | EXTREME NETWORKS INC | $2.24B | $16.77 | $23.50 | 40.13% | 46.09% | Strong Buy | Strong Buy | 4 | 2 | 7.53% | 176.51% | 281.49% | 16.74% |
| ANIP | ANI PHARMACEUTICALS INC | $1.81B | $80.73 | $108.20 | 34.03% | 25.93% | Strong Buy | Strong Buy | 5 | 3 | 8.58% | 77.56% | 47.15% | 16.94% |
| BLBD | BLUE BIRD CORP | $1.65B | $51.98 | $68.25 | 31.30% | 22.16% | Strong Buy | Strong Buy | 4 | 2 | 3.86% | 8.57% | 62.06% | 25.35% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.59B | $7.53 | $20.67 | 174.46% | 178.88% | Strong Buy | Strong Buy | 9 | 7 | 7.28% | N/A | -52.87% | 45.94% |
| DNOW | DNOW INC | $1.43B | $13.62 | $17.33 | 27.26% | 24.82% | Strong Buy | Strong Buy | 3 | 2 | 36.74% | 13.59% | 10.33% | 7.36% |
| ANAB | ANAPTYSBIO INC | $1.39B | $50.04 | $62.56 | 25.01% | 27.90% | Strong Buy | Strong Buy | 9 | 8 | 4.03% | N/A | N/A | -24.98% |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | $1.23B | $46.37 | $63.50 | 36.94% | 36.94% | Strong Buy | Strong Buy | 2 | 2 | 2.84% | 103.34% | 32.50% | 16.84% |
| TBLA | TABOOLACOM LTD | $1.20B | $4.16 | $5.25 | 26.20% | 26.20% | Strong Buy | Strong Buy | 2 | 2 | 5.12% | 91.82% | 12.26% | 7.30% |
| NUTX | NUTEX HEALTH INC | $1.18B | $167.34 | $252.50 | 50.89% | 79.28% | Strong Buy | Strong Buy | 2 | 1 | 2.78% | -0.06% | 59.00% | 19.40% |
| CRTO | CRITEO SA | $1.07B | $20.39 | $41.60 | 104.02% | 108.44% | Strong Buy | Strong Buy | 5 | 4 | -11.04% | 18.83% | N/A | N/A |
| TBPH | THERAVANCE BIOPHARMA INC | $940.99M | $18.57 | $28.75 | 54.82% | 57.96% | Strong Buy | Strong Buy | 4 | 3 | 14.72% | N/A | 17.92% | 10.04% |
| ORGO | ORGANOGENESIS HOLDINGS INC | $729.74M | $5.75 | $9.00 | 56.52% | 56.52% | Strong Buy | Strong Buy | 2 | 1 | 9.90% | N/A | 18.27% | 9.14% |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | $515.71M | $13.82 | $22.50 | 62.81% | 62.81% | Strong Buy | Strong Buy | 2 | 1 | 346.68% | N/A | 1,978.62% | 253.80% |
| VREX | VAREX IMAGING CORP | $502.90M | $12.06 | $16.67 | 38.20% | 32.67% | Strong Buy | Strong Buy | 3 | 1 | 4.47% | N/A | 9.00% | 3.84% |
| LE | LANDS' END INC | $434.44M | $14.22 | $20.00 | 40.65% | 40.65% | Strong Buy | Strong Buy | 2 | 1 | 4.12% | 59.60% | 12.46% | 3.38% |
| EGHT | 8X8 INC | $273.12M | $1.97 | $2.50 | 26.90% | 26.90% | Strong Buy | Strong Buy | 1 | 1 | 1.55% | N/A | 37.38% | 7.42% |
| OPRX | OPTIMIZERX CORP | $237.48M | $12.74 | $19.67 | 54.37% | 41.29% | Buy | Strong Buy | 3 | 1 | 5.95% | N/A | 16.33% | 11.72% |
| ELMD | ELECTROMED INC | $228.11M | $27.35 | $36.00 | 31.63% | 31.63% | Strong Buy | Strong Buy | 2 | 1 | 9.19% | 9.20% | 20.91% | 17.45% |
| LTRX | LANTRONIX INC | $226.31M | $5.75 | $7.75 | 34.78% | 34.78% | Strong Buy | Strong Buy | 2 | 2 | 10.73% | N/A | 17.44% | 10.86% |
| CXDO | CREXENDO INC | $202.82M | $6.60 | $9.13 | 38.26% | 66.67% | Strong Buy | Strong Buy | 4 | 1 | 8.29% | 57.55% | 20.44% | 16.51% |
| INFU | INFUSYSTEM HOLDINGS INC | $183.84M | $9.04 | $14.50 | 60.40% | 54.87% | Strong Buy | Strong Buy | 2 | 1 | 4.83% | 23.95% | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.